FDA
-
-
-
-
-
-
-
FDA grants fast track status to Verastem's lung cancer drug VS-7375
-
-
-
-
-
-
-
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
-
-
-
-
-
-
-
Verastem Oncology names new chairman, president of development
-
-
-
-
-
-
-
Verastem Oncology reports early trial data for KRAS G12D cancer drug
-
-
-
-
-
-
-
Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
-
-
-
-
-
-
-
Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade S
-
-
-
-
-
-
-
Verastem Oncology Reports First Quarter 2025 Financial Results and Highlights Recent Business Updates
-
323,406 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

